Study on the Role of 5-fluorouracil in the Polymerization of Butylcyanoacrylate during the Formation of Nanoparticles

References

• Blagoeva, P., Balanski, R., Mircheva, T. and Simeonova, M. (1992) “Diminished genotoxicity of Mitomycin C and Farmorubicin included in poybutylcyanoacrylate nanoparticles”, Mutat. Res. 268, 77–82.
   Google Scholar
• Blicharska, B. and Kupka, T. (2002) “Theoretical DFT and experimental NMR studies on uracil and 5-fluorouracil”, J. Mol. Struct. 613, 153–166.
   Web of Science ®Google Scholar
• Brigger, I., Dubernet, C. and Couvreur, P. (2002) “Nanoparticles in cancer therapy and diagnosis”, Adv. Drug Deliv. Rev. 54, 631–651.
   PubMed Web of Science ®Google Scholar
• Chiannilkulchai, N., Driouich, Z., Benoit, J.P., Parodi, A.L. and Couvreur, P. (1989) “Doxorubicin-loaded nanoparticles: increased efficiency in murine hepatic metastases”, Sel. Cancer Ther. 5, 1–11.
   Google Scholar
• Cooke, J.W.B., Bright, R., Coleman, M.J. and Jenkins, K.P. (2001) “Process research and development of a dihydropyrimidine dehydrogenase inactivator: large-scale preparation of enuracil using a sonogashira coupling”, Organic Process Res. & Develop. 5, 383–386.
   Google Scholar
• Couvreur, P., Tulkens, P., Roland, M., Trouet, A. and Speiser, P. (1977) “Nanocapsules, a new lysosomotropic carrier”, FEBS Lett. 84, 323–326.
   PubMed Web of Science ®Google Scholar
• Couvreur, P., Kante, B., Roland, M. and Speiser, P. (1979) “Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their related characteristics in a calf serum medium”, J. Pharm. Sci. 68, 1521–1524.
   PubMed Web of Science ®Google Scholar
• De Verdie`re, C.A., Dubernet, C., Nemati, F., Soma, E., Appel, M., Ferte´, J., Bernard, S., Puisieux, F. and Couvreur, P. (1997) “Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action”, Br. J. Cancer 76, 198–205.
   Web of Science ®Google Scholar
• Donnelly, E.F., Johnston, D.S., Pepper, D.C. and Dun, D.J. (1977) “Ionic and zwitterionic polymerization of n-alkyl 2-cyanoacrylates”, J. Polym. Sci., Polym. Lett. Ed. 15, 399–405.
   Web of Science ®Google Scholar
• Eromosele, I.C., Pepper, D.C. and Ryan, B. (1989) “Water effect on the zwitterionic polymerisation of cyanoacrylates”, Makromol. Chem. 190, 1613–1622.
   Google Scholar
• Fallon, L., III (1973) “The crystal and molecular structure of 5-fluorouracil”, Acta Crystallogr., B 29, 2549–2556.
   Google Scholar
• Gaspar, R., Preat, V. and Roland, M. (1991) “Nanoparticles of polyisohexylcyanoacrylate (PIHCA) as carriers for primaquine: formulation, physico-chemical characterization and acute toxicity”, Int. J. Pharm. 68, 111–119.
   Google Scholar
• Grangier, J.L., Puygrenier, M., Gautier, J.C. and Couvreur, P. (1991) “Nanoparticles as carriers for growth hormone releasing factor”, J. Control. Release 15, 3–13.
   Web of Science ®Google Scholar
• Guise, V., Drouin, J.Y., Benoit, J., Mahuteau, J., Genin, I. and Couvreur, P. (1990) “Vidarabine-loaded nanoparticles: a physico-chemical study”, Pharm. Res. 7, 736–741.
   Google Scholar
• Gulyaev, A.E., Gelperina, S.E., Skidan, I.N., Antropov, A.S., Kivman, G.Y. and Kreuter, J. (1999) “Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles”, Pharm. Res. 16, 1564–1569.
   Google Scholar
• Gupta, O.D., Twamley, B., Kirchmeier, R.L. and Shreeve, J.M. (2000) “Synthesis of N-polyfluorinated alkyl derivatives of uracil and 5-substitued uracils. X-ray structure of mono N-substituted 5-trifluoromethyluracil”, J. Fluorine Chem. 106, 199–204.
   Web of Science ®Google Scholar
• Heidelberger, C., Chudhuri, N.K., Dannerberg, P., Dangnerberg, P., et al. (1957) “Fluorinated pyrimidines, a new class of tumor-inhibitory compounds”, Nature 79, 663–665.
   Google Scholar
• Kante, B., Couvreur, P., Dubois-Krack, G., De Meester, C., Guiot, P., Roland, M., Mercier, M. and Speiser, P. (1982) “Toxicity of polycyanoacrylate nanoparticles I: free nanoparticles”, J. Pharm. Sci. 71, 786–790.
   PubMed Web of Science ®Google Scholar
• Kauffman, J.M., Seugupta, S.K. and Foye, W.O. (1989) “Cancer chemotherapy”, In: Foye, W.O., ed, Principles of Medicinal Chemistry, 3rd Ed. (Vorghese Publishing House, Bombay), pp 768–769.
   Google Scholar
• Labib, A., Lenaerts, V., Chouinard, F., Leroux, J-Chr., Quellet, R. and van Lier, J.E. (1991) “Biodegradable nanospheres containing phtalo- cyanines and naphtalocyanines for targeted photodynamic tumor therapy”, Pharm. Res. 8, 1027–1031.
   Google Scholar
• Lenaerts, V., Couvreur, P., Christiaens-Leyh, D., Joiris, E., Roland, M., Rollman, B. and Speiser, P. (1984) “Degradation of poly(isobutyl) cyanoacrylate nanoparticles”, Biomaterials 5, 65–68.
   PubMed Web of Science ®Google Scholar
• Lyeh, D., Couvreur, P., Lenaerts, V., Roland, M. and Speiser, P. (1984) “Etude du mechanisme de degradation des nanoparticules de polycyanoacrylate d’alkyl”, Labo-Pharma Probl. Tech. 32, 100–104.
   Google Scholar
• Nagase, T., Seike, K., Shiraishi, K., Yamada, Y. and Ozaki, S. (1988) “Application of the benzyloxycarbonyloxymethyl moiety to a protective group of 5-fluorouracil. Selective Alkylation of Amide Nitrogen of the Uracil Ring”, Chem. Lett. 8, 1381–1384.
   Google Scholar
• Pepper, D.C. (1978) “Anionic and zwitterionic polymerization of a-cyanoacrylates”, J. Polym. Sci.: Polym. Symp. 62, 65–77.
   Google Scholar
• Raic-Malic, S., Hergold-Brundic, A., Nagl, A., Grdisa, M. and Pavelic, K. (1999) “Novel pyrimidine and purine derivatives of L-ascorbic acid: synthesis and biological evaluation”, J. Med. Chem. 42, 2673–2678.
   Web of Science ®Google Scholar
• Schmidt, M.W., Baldridge, K.K., Boatz, J.A., Elbert, S.T., Gordon, M.S., Jensen, J.H., Koseki, S., Matsunaga, N., Ngugen, K.A., Su, S., Windus, T.L., Dupuis, M. and Montgomery, J.A. (1993) “General atomic and molecular electronic structure system”, J. Comput. Chem. 14, 1347–1363.
   Google Scholar
• Simeonova, M., Velichkova, R., Ivanova, G., Enchev, V. and Abrahams, I. (2003) “Poly(butylcyanoacrylate) nanoparticles for topical delivery of 5-fluorouracil”, Int. J. Pharm. 263, 133–140.
   Google Scholar
• Soma, C.E., Dubernet, C., Bentolila, D., Benita, S. and Couvreur, P. (2000) “Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nano- particles”, Biomaterials 21, 1–7.
   PubMed Web of Science ®Google Scholar
• Verdun, C., Couvreur, P., Vranckx, H., Lenaerts, V. and Roland, M. (1986) “Development of a nanoparticle controlled-release formula- tion for human use”, J. Control. Release 3, 205–210.
   Google Scholar